What is Ezetimibe?

Ezetimibe is a new-generation drug used to reduce total cholesterol and, specifically, LDL cholesterol, helping prevent cardiovascular disease. Statins, which act primarily at the liver level, ezetimibe works through a distinct mechanism: it blocks the absorption of cholesterol in the intestine, both from food and from bile, unlike it from entering the bloodstream.

Precisely thanks to this complementary mechanism, ezetimibe is effectively combined with statins, enhancing their lipid-lowering action without significantly increasing the load on the liver.

The drug is particularly useful in athletes using PEDs, especially anabolic steroids (AAS) , known to alter the lipid profile by increasing LDL and reducing HDL, resulting in an increased cardiovascular risk.

Main effects of Ezetimibe

📉 Significant reduction in LDL cholesterol
🔽 Moderate reduction in total cholesterol and triglycerides
🛡️ Better maintenance of HDL levels when combined with statins (eg pitavastatin)
🍃 Less liver impact compared to statin therapy alone
🫀 Additional cardiovascular support for PED users

How to take Ezetimibe

Dosage and how to use

During AAS use, ezetimibe is taken at the same dosage for the duration of the cycle, continuing for an additional 4–6 weeks after the end of the cycle to stabilize the lipid profile and protect the cardiovascular system.

The standard dose of 10 mg per day is generally sufficient and does not require increments. Continuation or modification of therapy should be based on periodic monitoring of lipids (LDL, HDL, total cholesterol, triglycerides) and liver enzymes (ALT, AST).

Precautions

• Avoid association with ciclosporin (possible increase in plasma concentrations).

• Monitor liver function during combination therapy with statins.

• Use with caution in the presence of pre-existing liver disease.

Possible side effects

• Mild gastrointestinal disturbances (diarrhea, abdominal pain)

• Headache

• Fatigue

• In combination with statins, possible increased risk of muscle pain compared to monotherapy

Conservation

Store in a dry place, below 25°C, away from sunlight. For related guidance, see Testolone 10mg – RAD 140 – SARMS.
Keep out of reach of children and do not use after the expiration date.

Mechanism of action of Ezetimibe

Ezetimibe acts in the small intestine, the primary site of dietary and bile cholesterol absorption. The drug selectively inhibits the transport protein NPC1L1 (Niemann-Pick C1-like 1), responsible for the passage of cholesterol from intestinal cells into the blood. By blocking this transporter, cholesterol is eliminated through the intestine rather than entering the circulation.

The reduction in absorbed cholesterol induces the liver to increase the expression of LDL receptors, promoting the removal of “bad” cholesterol from the blood and reducing its deposition on the vascular walls.

When combined with statins, which reduce hepatic cholesterol synthesis, the effect is synergistic and leads to a marked reduction in atherosclerotic risk. This combination is particularly recommended for athletes taking AAS, as these substances significantly alter lipid balance, increasing cardiovascular stress.

FAQ

Can ezetimibe be taken with statins such as pitavastatin, atorvastatin, or rosuvastatin?
Yes, the combination is common and allows for more effective LDL cholesterol reduction.

Does it negatively affect training or muscle recovery?
No, ezetimibe does not impair muscle function or recovery time.

Does it reduce the absorption of vitamins or nutrients?
At high doses, it may slightly reduce the absorption of fat-soluble vitamins (A, D, E, and K), a rare occurrence with standard dosages.